trending Market Intelligence /marketintelligence/en/news-insights/trending/Ydc8uNms-K_P2e_QKuMWtw2 content esgSubNav
In This List

AngioSoma names CEO

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

AngioSoma names CEO

AngioSoma Inc. named Ken Stephenson as CEO and president, and appointed him to the board.

Stephenson will focus on bridging the gap between the company's solution, current standard-of-care treatments, and reimbursement by Medicare, Medicaid, and private insurance companies to these medical professionals, according to a news release.

AngioSoma also named Alexanderia Blankenship as COO and executive vice president.